Rep. Ryan Mackenzie

Maddy summaryHRES 702 is a symbolic resolution condemning the September 10, 2025, assassination of Charlie Kirk, founder of Turning Point USA and a conservative political activist. It expresses condolences to his family, praises first responders, and reaffirms the right to peaceful assembly. As a non-binding resolution, it does not create new laws or policies but serves as a formal statement of condemnation. The resolution directly addresses the House of Representatives' stance on this event, with no direct impact on constituents or legislation.

Maddy summaryHR 5329, the Regional China Officer Authorization Act, establishes a formal program within the State Department to deploy 20 Regional China Officers (RCOs) across U.S. diplomatic posts worldwide. These officers will monitor China’s activities in commerce, infrastructure, technology, and military domains - including Belt and Road projects - and advise U.S. embassies and allied governments on countering China’s influence. The bill authorizes $2.5 million annually (2026-2030) for program expansion and management, including support staff for regional offices, and expires after five years. It directly affects U.S. diplomatic missions, allied governments, and Foreign Service officers selected for RCO roles based on China expertise and language skills.

Maddy summaryThis bill reauthorizes the existing program providing support and treatment services for law enforcement officers experiencing mental health crises. It extends the funding authorization period from 2020-2024 to 2025-2029 under the Omnibus Crime Control and Safe Streets Act of 1968. The bill directly affects law enforcement officers who access these crisis support services through participating state and local programs. It makes no new policy changes but ensures the current program continues operating without interruption for five additional years.

Maddy summaryThe RESULTS Act (HR 5269) changes how Medicare calculates payment rates for clinical diagnostic laboratory tests. It requires Medicare to collect data on private payor rates for widely available non-Advanced Diagnostic Laboratory Tests (non-ADLTs) from a qualifying independent claims data entity (a national nonprofit organization meeting specific criteria) rather than relying on data reported directly by laboratories. For tests where data is unavailable, the bill establishes default payment rates based on previous years' rates adjusted for inflation. The law also requires Medicare to publicly explain payment rates with supporting data, affecting Medicare beneficiaries, clinical laboratories, and private payors that provide services covered by Medicare.

Maddy summaryThis bill directs the U.S. President to identify Pakistani officials responsible for undermining democracy and human rights within 180 days of enactment, then impose Global Magnitsky sanctions on them. It targets senior government, military, or security officials found to have committed gross human rights violations or interfered with democratic processes, such as during Pakistan’s 2024 elections or through constitutional changes. Sanctions would include asset freezes and travel bans, with exceptions for humanitarian aid, UN obligations, and national security activities. The bill expires on September 30, 2030, and aims to pressure Pakistan to uphold democratic norms, human rights, and judicial independence.

Maddy summaryThis bill ensures U.S. Border Patrol Agents and Customs and Border Protection officers who continue working during a government shutdown receive their salaries. It authorizes funding from the Treasury for fiscal year 2026 to cover their salaries and expenses during any lapse in discretionary appropriations. The measure specifically applies to employees "excepted from furlough," meaning those required to work during shutdowns. It does not change eligibility for pay but guarantees funding for these personnel during funding gaps.

Maddy summaryThis bill prohibits Members of Congress, their spouses, and dependent children from owning or trading certain investments, including stocks, commodities, and derivatives (referred to as "covered investments"). It requires affected individuals to divest these investments within 90-180 days, with specific exemptions for Treasury bonds, diversified mutual funds, small business interests, and family trusts meeting strict conditions. Violations incur penalties of 10% of the investment's value plus disgorgement of profits, paid directly to the U.S. Treasury. The law applies to all covered individuals during federal service, with exceptions for investments acquired through inheritance or occupational trading (e.g., a spouse’s finance job).

Maddy summaryHR 5024, the Transit Funding Flexibility Act, removes a population restriction that previously limited certain federal transit grants to urban areas with fewer than 200,000 residents. It requires transit agencies receiving these grants to annually certify they maintain local funding for operating costs covered by federal money. If an agency fails to maintain this local funding, the bill mandates a 1/3 reduction in their next year's federal grant amount. This bill directly affects public transit agencies in smaller urban areas that now gain access to operating cost funding, while requiring them to sustain local financial commitments.

Maddy summaryHR 5032, the Nitazene Control Act, permanently classifies all nitazenes and their chemical analogs as Schedule I controlled substances under the Controlled Substances Act. This means these synthetic opioids, which are significantly more potent than fentanyl and linked to overdose deaths, are now federally banned for all non-medical use. The bill creates a broad chemical definition covering substances with specific structural features (a benzimidazole core and mu-opioid receptor activity), preventing new analogs from evading regulation. It includes a temporary 18-month exemption for researchers already studying these substances under active FDA-approved protocols, requiring them to notify the DEA and apply for proper registration within that period. The law directly affects the illicit drug market and ongoing research involving nitazenes, aiming to streamline enforcement and prevent new analogs from entering the supply chain.

Maddy summaryHR 5031, the *Preserving Patient Access to Long-Term Care Pharmacies Act*, requires Medicare Part D plans and Medicare Advantage plans with drug coverage (MA-PD) to pay long-term care pharmacies an additional supply fee for each specified prescription dispensed to eligible beneficiaries during 2026 ($30) and 2027 (adjusted for inflation). This fee must be paid alongside existing reimbursements for drug costs and dispensing, with a $10,000 penalty for non-payment. The bill also directs the GAO to study long-term care pharmacy payment sustainability under Medicare, analyzing historical payments for brand/generic drugs and dispensing fees. It aims to ensure uninterrupted pharmacy access for Medicare beneficiaries in long-term care settings, particularly in rural areas.